Cy2-Streptavidin, 1 mg

SECTION 2: Hazards identification

This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Odor Solid. Odorless.

Potential Acute Health Effects

Eyes Skin Inhalation Moderately irritating to eyes. Harmful in contact with skin. Moderately irritating to the skin. May cause sensitization by skin contact. Toxic by inhalation. Moderately irritating to the respiratory system. May cause sensitization by inhalation. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Harmful if swallowed. Potential chronic health effects

Potential chronic health

Contains material that may cause target organ damage, based on animal data. Once sensitized, a severe allergic reaction may occur when subsequently exposed to very low levels. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.

Teratogenic Effects

No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects Target organs No known significant effects or critical hazards. Contains material which may cause damage to the following organs: mucous membranes, gastrointestinal tract, skin, eyes, stomach. Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing wheezing and breathing difficulties asthma Ingestion Skin No specific data. Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: irritation watering redness

Medical Conditions Generally Aggravated by Exposure

Pre-existing respiratory and skin disorders and disorders involving any other target organs mentioned in over-exposure this MSDS as being at risk may be aggravated by over-exposure to this product. See toxicological information (section 11)